Skip to main content
Log in

An Inframe Trinucleotide Deletion in MTRR Exon 1 is Associated with the Risk of Spina Bifida

  • Original Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

Maternal genetic variants of enzymes in folate–homocysteine metabolic network are significantly correlative with the risk of spina bifida. To survey the genetic causality, the genotypes of three women having spina bifida fetuses from two unrelated Chinese families were screened in candidate alleles. Polymerase chain reaction, capillary electrophoresis and Sanger sequencing were employed to recognize the allelic variation. A trinucleotide deletion (c.4_6delAGG) was identified in the first exon of MTRR. All the three women showed the novel clinical variation including one heterozygous and two homozygous. The siblings who had healthy babies from the same families did not harbor the variation. In the unaffected control individuals, the variant was also not observed. Eukaryotic expression and bioinformatics techniques were utilized to explore the molecular pathogenesis of the potential genetic risk of developing spina bifida. Exceptionally, the functional examination revealed that the Arg2del variant kept subcellular localization unaltered with catalytic activity intact, but failed to efficiently activate MTR compared with the wild type. Genetic disorder of folate and homocysteine metabolism during pregnancy is believed to be associated with folate-sensitive neural tube defects. The report highlights that the inframe deletion in MTRR exon 1 could be a high risk factor susceptibility to spina bifida.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Blom, H. J., Shaw, G. M., den Heijer, M., & Finnell, R. H. (2006). Neural tube defects and folate: Case far from closed. Nature Reviews Neuroscience, 7(9), 724–731.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Christensen, B., Arbour, L., Tran, P., Leclerc, D., Sabbaghian, N., Platt, R., et al. (1999). Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. American Journal of Medical Genetics, 84(2), 151–157.

    Article  CAS  PubMed  Google Scholar 

  • Detrait, E. R., George, T. M., Etchevers, H. C., Gilbert, J. R., Vekemans, M., & Speer, M. C. (2005). Human neural tube defects: Developmental biology, epidemiology, and genetics. Neurotoxicology and Teratology, 27(3), 515–524. (Epub 2005 Mar 5).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Doolin, M. T., Barbaux, S., McDonnell, M., Hoess, K., Whitehead, A. S., & Mitchell, L. E. (2002). Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. American Journal of Human Genetics, 71(5), 1222–1226. (Epub 2002 Oct 9).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Froese, D. S., Wu, X., Zhang, J., Dumas, R., Schoel, W. M., Amrein, M., et al. (2008). Restricted role for methionine synthase reductase defined by subcellular localization. Molecular Genetics and Metabolism, 94(1), 68–77. doi:10.1016/j.ymgme.2007.11.019. (Epub 2008 Jan 24).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Greene, N. D., & Copp, A. J. (2014). Neural tube defects. Annual Review of Neuroscience, 37, 221–242. doi:10.1146/annurev-neuro-062012-170354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Imbard, A., Benoist, J. F., & Blom, H. J. (2013a). Neural tube defects, folic acid and methylation. International Journal of Environmental Research and Public Health, 10(9), 4352–4389. doi:10.3390/ijerph10094352.

    Article  PubMed  PubMed Central  Google Scholar 

  • Imbard, A., Benoist, J. F., & Blom, H. J. (2013b). Neural tube defects, folic acid and methylation. International Journal of Environmental Research and Public Health, 10(9), 4352–4389. doi:10.3390/ijerph10094352.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jiang, J., Zhang, Y., Wei, L., Sun, Z., & Liu, Z. (2014). Association between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: A meta-analysis. PLoS ONE, 9(6), e101169. doi:10.1371/journal.pone.0101169. (eCollection 2014).

    Article  PubMed  PubMed Central  Google Scholar 

  • Johnson, W. G., Stenroos, E. S., Spychala, J. R., Chatkupt, S., Ming, S. X., & Buyske, S. (2004). New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? American Journal of Medical Genetics Part A, 124A(4), 339–345.

    Article  PubMed  Google Scholar 

  • Relton, C. L., Wilding, C. S., Pearce, M. S., Laffling, A. J., Jonas, P. A., Lynch, S. A., et al. (2004). Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. Journal of Medical Genetics, 41(4), 256–260.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ross, M. E. (2010). Gene-environment interactions, folate metabolism and the embryonic nervous system. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2(4), 471–480. doi:10.1002/wsbm.72.

    CAS  PubMed  PubMed Central  Google Scholar 

  • van der Put, N. M., Steegers-Theunissen, R. P., Frosst, P., Trijbels, F. J., Eskes, T. K., van den Heuvel, L. P., et al. (1995). Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet, 346(8982), 1070–1071.

    Article  PubMed  Google Scholar 

  • Wang, Y., Liu, Y., Ji, W., Qin, H., Wu, H., Xu, D., et al. (2015). Analysis of MTR and MTRR polymorphisms for neural tube defects risk association. Medicine (Baltimore), 94(35), e1367. doi:10.1097/MD.0000000000001367.

    Article  CAS  Google Scholar 

  • Wilson, A., Platt, R., Wu, Q., Leclerc, D., Christensen, B., Yang, H., et al. (1999). A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Molecular Genetics and Metabolism, 67(4), 317–323.

    Article  CAS  PubMed  Google Scholar 

  • Yamada, K., Gravel, R. A., Toraya, T., & Matthews, R. G. (2006). Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proceedings of the National Academy of Sciences, 103(25), 9476–9481. (Epub 2006 Jun 12).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledged all the patients, family members and control participants in providing specimens and clinical data for this study. The work was funded by the grants from Chongqing Municipal Education Commission (KJ080301), Chongqing Science & Technology Commission (CSTC, 2010BB5366) and National Natural Science Foundation of China (NO. 20803098).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Zhang.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Additional information

Xiao-lu Dai and Gui-cen Liu are co-first authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Fig. s1

Pedigrees of the two families. In the family trees, the black circles represent the females who experienced spina bifida-affected pregnancy. The white circles signify the unaffected ones. Lack of allele information, the male or female mutation carrier could not be distinguished in the both families. The pedigree of family 1 is displayed on the left, family 2 on the right. The black arrows refer to the probands in the pedigrees. (TIFF 17592 kb)

Supplementary material 2 (DOC 24 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, J., Dai, Xl., Liu, Gc. et al. An Inframe Trinucleotide Deletion in MTRR Exon 1 is Associated with the Risk of Spina Bifida. Neuromol Med 19, 387–394 (2017). https://doi.org/10.1007/s12017-017-8452-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-017-8452-z

Keywords

Navigation